Search 7,500+ licensed pharmacies to find the best value, closest location, and fastest turnaround for
.
Estriol (E3) is the weakest of the three main human estrogens, acting predominantly on estrogen receptors in vaginal, urinary, and mucosal tissue. Its weaker systemic potency and shorter receptor binding duration make it the preferred estrogen for local genitourinary applications and as a safer BHRT component.
Commercial estriol creams are not FDA-approved in the US (though Imvexxy/estradiol is). Compounding allows estriol-only preparations for vaginal use, custom Bi-est (estradiol + estriol) and Tri-est (E1+E2+E3) formulas, and precise ratio control for individualized BHRT.
Compare up to 7,500 pharmacies across the USA.
Estriol (E3) is the third major human estrogen and the predominant estrogen of pregnancy. It is the weakest of the three estrogens (E1 estrone, E2 estradiol, E3 estriol) and is characterized by shorter receptor binding duration, predominantly local rather than systemic activity, and a more favorable safety profile for long-term use in genitourinary tissue.
In BHRT, estriol is used in Bi-est (estradiol + estriol, typically 80:20 ratio) and Tri-est (estrone + estradiol + estriol) combinations. Many integrative practitioners prefer Bi-est over estradiol alone based on the belief that estriol's presence modulates estradiol's more potent receptor activity — a concept supported by some but not all research.
Topical vaginal estriol is highly effective for genitourinary syndrome of menopause (GSM) — vaginal atrophy, dryness, dyspareunia, and recurrent UTIs — with minimal systemic absorption at low doses.
Vaginal atrophy and dryness (GSM), recurrent urinary tract infections, dyspareunia (painful intercourse), BHRT Bi-est/Tri-est formulations, urinary incontinence adjunct
Vaginal cream (0.5–1mg/g): Apply 0.5–1g vaginally nightly for 2 weeks then 2–3x per week maintenance
Bi-est transdermal: 0.5–2mg total estrogen daily based on provider titration
Individualized based on hormone levels and symptom response
Vaginal: minimal with local application. Systemic Bi-est/Tri-est: breast tenderness, spotting, fluid retention. Estriol has significantly lower systemic potency than estradiol — side effects are generally milder.
Submit a quote request to find the lowest price. Quotes delivered to your inbox.
Find Lowest Price.png){kind=spacer}
